# Predicting Medication Response for Autoimmune Disease

> **NCT04995783** · — · TERMINATED · sponsor: **Coral Genomics, Inc.** · enrollment: 200 (actual)

## Conditions studied

- Ulcerative Colitis
- Crohn's Disease
- Psoriasis
- Rheumatoid Arthritis

## Interventions

- **DIAGNOSTIC_TEST:** Coral FRS test

## Key facts

- **NCT ID:** NCT04995783
- **Lead sponsor:** Coral Genomics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 200 (ACTUAL)
- **Why stopped:** Coral underwent an APA and is no longer in operation
- **Last updated:** 2023-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04995783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04995783, "Predicting Medication Response for Autoimmune Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04995783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*